Table 1

Patients features

Males/Females5/0
Mean age (SD)54 (±6.69)
ComorbiditiesObesity (1),previous colorectal cancer (1), hemiplegia (1), none (2)
Mean P/F at TCZ administration176.2 (±42.97)
Ventilation support at TCZ administrationVM (3), IV(2)
Mean P/F at MP administration204.4 (±29.97)
Ventilation support at MP administrationIV (3), VM (2)
Mean P/F 7 days after MP administration327.8 (±59.86) *
Ventilation support 7 days after MP administrationVM (4), AA (1)
  • *P<0.01.

  • AA, ambient air; IV, invasive ventilation; MP, methylprednisolone; P/F, PaO2/FiO2 ratio; TCZ, tocilizumab; VM, ventimask.